SPNE News and Press, SeaSpine Holdings Corporation From 04/28/22

CARLSBAD, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Explorer ® TO (TLIF Oblique)...

CARLSBAD, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release first quarter financial results after the close of...

SeaSpine Holdings Corp. (NASDAQ:SPNE) has begun the full commercial launch of its Reef TA (TLIF Articulating) Interbody System. The company said that the system delivers an interbody to the anterior portion of the disc space to optimize sagittal alignment and endplate support. In Novembe...

CARLSBAD, Calif., April 11, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of the Reef TA (TLIF Articulating) Interbody...

CARLSBAD, Calif., March 24, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the implantation of the 50,000th NanoMetalene ® interbody devi...

CARLSBAD, Calif., March 15, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company will participate in the Canaccord Musculoskeletal Conf...

SeaSpine press release (NASDAQ:SPNE): Q4 GAAP EPS of -$0.52 misses by $0.20. Revenue of $55.6M (+19.8% Y/Y) beats by $0.24M. Shares +1.34%. For further details see: SeaSpine GAAP EPS of -$0.52 misses by $0.20, revenue of $55.6M beats by $0.24M

CARLSBAD, Calif., March 11, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today financial results for the three-months and full-year ended December 31,...

CARLSBAD, Calif., March 07, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the elevation of Dr. Frank Vizesi to Chief Scientific Officer and ...

CARLSBAD, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of NorthStar™ Cervical Facet Fusion a...